Jiangsu Key Laboratory of Biofunctional Material, College of Chemistry and Material Science, Nanjing Normal University, Nanjing 210023, China.
Jiangsu Key Laboratory of Biofunctional Material, College of Chemistry and Material Science, Nanjing Normal University, Nanjing 210023, China.
Mater Sci Eng C Mater Biol Appl. 2018 Aug 1;89:422-428. doi: 10.1016/j.msec.2018.04.024. Epub 2018 Apr 12.
Nearly monodispersed magnetic FeO@MTX-LDH/Au nanoparticles (NPs) containing the anticancer agent of methotrexate (MTX) were prepared via a coprecipitation-electrostatic interaction strategy. Firstly, layered double hydroxide (LDH) materials were deposited over the surface of FeO NPs by the coprecipitation method. Secondly, Au NPs were successfully conjugated onto the surface of LDH through electrostatic interaction. Herein, MTX was used both as the agent for surface modification and the anticancer drug for chemotherapy. These particles presented well-defined core-shell structure, strong magnetization and a high drug-loading capacity. Furthermore, the combined treatment of cancer cells by using FeO@MTX-LDH/Au for synergistic hyperthermia ablation and chemotherapy was demonstrated to exhibit higher therapeutic efficacy than either single treatment alone, underscoring the great potential of the platform for cancer therapy.
通过共沉淀-静电相互作用策略制备了载有抗癌药物甲氨蝶呤(MTX)的近乎单分散的磁性 FeO@MTX-LDH/Au 纳米粒子(NPs)。首先,通过共沉淀法将层状双氢氧化物(LDH)材料沉积在 FeO NPs 的表面上。其次,通过静电相互作用成功地将 Au NPs 接枝到 LDH 的表面上。在此,MTX 既用作表面改性剂,也用作化疗的抗癌药物。这些粒子呈现出明确的核壳结构、强磁化和高载药能力。此外,通过使用 FeO@MTX-LDH/Au 进行协同热疗消融和化疗联合治疗癌细胞,证明其疗效明显高于单一治疗,突出了该平台在癌症治疗方面的巨大潜力。